Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers February 15, 2019
Pharmacy Choice - Pharmaceutical News - PAREXEL Collaborates with Eli Lilly and Company to Develop Chinas Clinical Research Workforce [Sudan Tribune] - February 15, 2019

Pharmacy News Article

 12/6/18 - PAREXEL Collaborates with Eli Lilly and Company to Develop Chinas Clinical Research Workforce [Sudan Tribune]

PAREXEL, a leading innovator of global biopharmaceutical services, today announced a new collaboration with Eli Lilly and Company to launch a clinical research learning and development program in China. The program will bring high-value training opportunities to Chinas clinical trial sites and investigators, enhancing the execution of local clinical trials and driving innovation in Chinas biopharmaceutical industry.

To encourage innovation in drug development, the Chinese government recently released a series of new policies for clinical research, resulting in a sharp increase in the number of clinical trials in China. According to Chinas clinical trial registration platform, 1,258 drug clinical trials were registered and publicized for the first time in China in 2017, an increase of 62.66 percent compared to 2016. This increase in clinical research demands has put a strain on the clinical research capacity and resources in China. A recent report indicates that the total number of class 1.1 chemical drugs and class 1 biologic drugs approved for clinical trials from January to October 2017 was three times that of 2014. Still, the number of GCP-qualified clinical trial sites did not significantly increase between 2014 and 2016.

PAREXEL and Lillys collaboration is based on a shared vision to address this unmet need and promote globalization and innovation of the markets drug development. The joint program will use curriculum developed by PAREXEL Academy for clinical trial investigators, and issue certifications to professionals who complete the training. Designed by clinical research practitioners, the curriculum combines the latest policies, regulations and clinical research technologies. It also uses behavior-oriented curriculum design, real-world cases, as well as advanced knowledge and industry trends, to provide world-class expertise and practical experience for clinical research investigators. The curriculum has been reviewed and certified by TransCelerate BioPharma, Inc., an international non-profit organization focused on biopharmaceutical research and development.

Dr. Albert Siu, Corporate Vice President, Global Learning & Development for PAREXEL, said, With its extensive global footprint, PAREXEL has accumulated rich expertise in global clinical trial management. We remain committed to providing advanced and comprehensive learning and development solutions for the worlds clinical trial sites and investigators. Based on our shared values and mission, PAREXEL is collaborating with Lilly to help even more clinical trial investigators in China and facilitate the innovation of Chinas biopharmaceutical industry.

Dr. Li Wang, senior vice president of drug development and medical affairs at Lilly, said, As one of the first international pharmaceutical companies to launch large-scale R&D activities in China, Lilly is deeply committed to helping grow Chinas clinical research workforce. We are confident that our collaboration with PAREXEL will bring more learning and development opportunities to clinical research investigators in China and help promote the globalization of Chinas drug clinical research.

A recent research report conducted by the Economist Intelligence Unit and commissioned by PAREXEL identified workforce readiness as a key enabler of innovation in the life sciences industry. The report noted that allocating proper resources for training individuals in aspects such as clinical trial coordination and execution, as well as standardizing how clinical research is conducted and how study coordinators are trained, could drive better output and improve consistency.

(c) 2003-2018 SudanTribune - All rights reserved. Provided by SyndiGate Media Inc. (

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Feb 18: Management of Schizophrenia & Acute Agitation
Feb 19: Treatment of Atopic Dermatitis (Eczema) & Xerosis (Dry Skin)
Feb 20: Know Your Value, Know Your Worth: Provider Status in Pharmacy
Feb 21: Type II Diabetes: Case Studies and Management Options
Feb 22: Medical Marijuana: The Basic and Clinical Pharmacology, Not The Politics
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement